Ferrer Freeman & Company, LLC Announces the Sale of Its Stake in Amerita, Inc.

GREENWICH, Conn.--()--Ferrer Freeman & Company, LLC (“FFC”), a healthcare focused private equity firm, today announced the sale of its interest in Amerita Inc. ("Amerita" or the "Company"), a provider of home and specialty infusion services, to PharMerica Corporation (NYSE: PMC). Terms of the transaction were not disclosed. Amerita, based in Irvine, CA, was formed in 2006 with capital from FFC and the Amerita management team. Through de novo development, acquisitions, and organic growth, the Company is now one of the nation’s largest independent providers of complex pharmaceutical products and clinical services to patients outside of the hospital, with 12 branches in Colorado, Oklahoma, Tennessee, Texas and Utah. As part of the transaction, Amerita CEO Jim Glynn will go forward as the President of Amerita, a wholly owned subsidiary of PharMerica.

“FFC is very proud to have been associated with Amerita throughout its growth and development”

"FFC is very proud to have been associated with Amerita throughout its growth and development," said David Freeman, a Founding Member at FFC. "Jim Glynn and the Amerita management team have built an organization with a patient centric approach that has achieved industry leading clinical outcomes and high levels of customer service. This outstanding service record is well recognized in the communities where Amerita operates and has been the driver of the Company’s impressive growth.”

"Amerita is representative of our core strategy of partnering with experienced management teams to take advantage of significant growth opportunities," added Freeman. "When we invested, demand for home infusion services was high as cost-containment pressures were shifting care from the institutional setting to the home. Amerita has taken full advantage of these market dynamics. We wish Jim and the rest of the Amerita team much success as they continue to grow the business."

Amerita CEO Jim Glynn commented, "FFC’s experience in building market leading companies and its relationships in the healthcare industry have been instrumental in helping us achieve the scale and success we have to date. We are very excited about the next stage of growth for Amerita as part of the PharMerica organization.”

The sale of Amerita to PharMerica represents the 11th exit for FFC since August 2010 and its 25th exit since inception.

CIT Capital Securities acted as financial advisor to Amerita in connection with the transaction. Goodwin Procter and Reed Smith provided legal counsel to the Company.

About Ferrer Freeman & Company, LLC

Ferrer Freeman & Company, LLC, is a private equity firm located in Greenwich, CT focused exclusively on growth capital investments in the healthcare industry. Since its founding in 1995, FFC has invested over $900 million in 36 portfolio companies. FFC invests in established companies with significant growth opportunities and entrepreneurial management teams. FFC has a demonstrated track record of leveraging its comprehensive healthcare network and decades of experience to help build market leading organizations. More information on FFC is available at www.ffandco.com.

About Amerita

Amerita, Inc. is a specialty infusion company focused on providing complex pharmaceutical products and clinical services to patients outside of the hospital. This market is expanding through a growing bio-pharmaceutical pipeline of infuseable and injectable medications, an aging population that requires additional healthcare services and the country’s need to find more affordable care alternatives. Amerita is headquartered at 20 Fairbanks, Suite 173, Irvine, CA 92618. More information on Amerita is available at www.ameritaiv.com.


For Ferrer Freeman & Company
Brunswick Group
Mary Zimmerman or Andrew Roth
mzimmerman@brunswickgroup.com, aroth@brunswickgroup.com